Literature DB >> 26897142

Kawasaki Disease in India, Lessons Learnt Over the Last 20 Years.

Surjit Singh1, Tomisaku Kawasaki.   

Abstract

Over the last 20 years, Kawasaki disease is being increasingly recognized in India and it may soon replace acute rheumatic fever to become the commonest cause of acquired heart disease amongst children. However, the vast majority of children with Kawasaki disease in India are still not being diagnosed. Diagnosis of Kawasaki disease is based on a constellation of clinical findings which have a typical temporal sequence. All pediatricians must we familiar with the nuances involved in arriving at a diagnosis of Kawasaki disease. With early diagnosis and prompt treatment, the risk of coronary artery abnormalities can be significantly reduced.

Entities:  

Mesh:

Year:  2016        PMID: 26897142     DOI: 10.1007/s13312-016-0804-5

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  7 in total

Review 1.  Kawasaki disease for dermatologists.

Authors:  Aman Gupta; Surjit Singh
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

Review 2.  The emergence of Kawasaki disease in India and China.

Authors:  Fuyong Jiao; Ankur Kumar Jindal; Vignesh Pandiarajan; Raju Khubchandani; Nutan Kamath; Tapas Sabui; Rakesh Mondal; Priyankar Pal; Surjit Singh
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

Review 3.  Diagnosis of Kawasaki disease.

Authors:  Surjit Singh; Ankur Kumar Jindal; Rakesh Kumar Pilania
Journal:  Int J Rheum Dis       Date:  2017-11-13       Impact factor: 2.454

Review 4.  Controversies in diagnosis and management of Kawasaki disease.

Authors:  Rakesh Kumar Pilania; Dharmagat Bhattarai; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2018-02-08

5.  Out-of-hospital cardiac arrest in a young adult survivor with sequelae of childhood Kawasaki disease: A case report.

Authors:  Ke-Fu Zhu; Li-Jiang Tang; Shao-Ze Wu; Yi-Min Tang
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

6.  Infliximab as a rescue therapy in the management of refractory typical infantile Kawasaki disease.

Authors:  K Venkatnarayanan; Harmeet S Arora; Aparajita Gupta; K M Adhikari
Journal:  Med J Armed Forces India       Date:  2018-10-06

Review 7.  What Lies Ahead for Young Hearts in the 21st Century - Is It Double Trouble of Acute Rheumatic Fever and Kawasaki Disease in Developing Countries?

Authors:  Aaqib Zaffar Banday; Sanjib Mondal; Prabal Barman; Archan Sil; Rajni Kumrah; Pandiarajan Vignesh; Surjit Singh
Journal:  Front Cardiovasc Med       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.